PDS Biotechnology Corporation Granted U.S. and European Patents for Versamune® - GM-CSF Combination to Overcome Tumor Immune Suppression

PDS Biotechnology Corporation Granted U.S. and European Patents for Versamune® – GM-CSF Combination to Overcome Tumor Immune Suppression

June 19, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search